(Q36059005)

11 August 2017

A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy (English)

1 reference

adaptive radiation therapy

11 August 2017

0 references

amifostine

1 reference

ChEBI release 2020-05-28

6

Edgar Ben-Josef

0 references

Daniel P. Normolle

object named as

Daniel P Normolle

3

0 references

author name string

Mary Feng

1

1 reference

11 August 2017

David E Smith

2

1 reference

11 August 2017

James A Knol

4

1 reference

11 August 2017

Charlie C Pan

5

1 reference

11 August 2017

Zheng Lu

7

1 reference

11 August 2017

Meihua R Feng

8

1 reference

11 August 2017

Jun Chen

9

1 reference

11 August 2017

William Ensminger

10

1 reference

11 August 2017

Theodore S Lawrence

11

1 reference

11 August 2017

language of work or name

English

0 references

publication date

21 March 2012

1 reference

International Journal of Radiation Oncology Biology Physics

11 August 2017

1 reference

11 August 2017

83

1 reference

11 August 2017

5

1 reference

11 August 2017

1441-1447

1 reference

Veno-occlusive disease of the liver

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Protection of Normal Tissues from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine (WR-2721): Preclinical Aspects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Tolerance of normal tissue to therapeutic irradiation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Designing dose-escalation trials with late-onset toxicities using the time-to-event continual reassessment method.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Impact on cytoprotective efficacy of intermediate interval between amifostine administration and radiotherapy: a retrospective analysis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Analysis of radiation-induced liver disease using the Lyman NTCP model.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: results of a phase I study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383372

Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography

23 September 2018

1 reference

12 December 2020

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

1 reference

12 December 2020

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

12 December 2020

Human pharmacokinetics of WR-2721

1 reference

12 December 2020

Pharmacokinetics of amifostine and its metabolites in patients

1 reference

12 December 2020

10.1016/J.IJROBP.2011.10.020

Identifiers

DOI

1 reference

release_czlecovzsvfq5c6il3dqpzmfgy

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/czlecovzsvfq5c6il3dqpzmfgy

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

PubMed publication ID

22440042

1 reference